FMP
NASDAQ
2.18 USD
0.02 (0.917%)
Mr. Thomas G. Wiggans
Healthcare
Biotechnology
https://www.pardesbio.com
NASDAQ
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.
0001822711
US69945Q1058
69945Q105
2173 Salk Avenue
415 649 8758
US
57
Dec 27, 2021